Over the last 7 days, the Biotech industry has dropped 1.9%, driven by a pullback from Oxford Biomedica of 9.9%. On the other hand Arecor Therapeutics is actually up 11%. However, the industry is down 29% over the past year. Earnings are forecast to grow by 19% annually.
Has the U.K. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 18 Mar 2024 | UK£3.1b | UK£897.7m | -UK£203,570,600.75 | 34.3x | -15x | 3.4x |
Wed, 14 Feb 2024 | UK£3.3b | UK£913.5m | -UK£198,137,488.45 | 31.1x | -16.7x | 3.6x |
Fri, 12 Jan 2024 | UK£6.3b | UK£1.3b | -UK£245,062,810.00 | 36.6x | -25.6x | 4.9x |
Sun, 10 Dec 2023 | UK£6.2b | UK£1.3b | -UK£245,939,365.00 | 36.9x | -25.1x | 4.9x |
Tue, 07 Nov 2023 | UK£6.4b | UK£1.3b | -UK£242,901,044.00 | 39.1x | -26.4x | 5x |
Thu, 05 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,253,107.00 | 37x | -25.8x | 5.1x |
Sat, 02 Sep 2023 | UK£6.7b | UK£1.3b | -UK£205,895,302.00 | 23.6x | -32.4x | 5.3x |
Mon, 31 Jul 2023 | UK£6.9b | UK£1.3b | -UK£208,643,030.00 | 23.6x | -33.2x | 5.5x |
Wed, 28 Jun 2023 | UK£6.8b | UK£1.3b | -UK£205,298,070.00 | 23.9x | -33x | 5.4x |
Fri, 26 May 2023 | UK£6.9b | UK£1.3b | -UK£207,220,434.00 | 23.2x | -33.5x | 5.5x |
Sun, 23 Apr 2023 | UK£7.2b | UK£1.2b | -UK£156,309,305.00 | 23.5x | -46x | 5.8x |
Tue, 21 Mar 2023 | UK£7.2b | UK£1.2b | -UK£157,701,448.00 | 25.1x | -45.4x | 5.8x |
Thu, 16 Feb 2023 | UK£7.4b | UK£1.2b | -UK£149,981,915.00 | 28.5x | -49.6x | 6.4x |
Sat, 14 Jan 2023 | UK£7.7b | UK£1.2b | -UK£140,802,051.00 | 28.5x | -54.6x | 6.6x |
Mon, 12 Dec 2022 | UK£7.5b | UK£1.2b | -UK£136,794,667.00 | 25x | -54.6x | 6.4x |
Wed, 09 Nov 2022 | UK£7.4b | UK£1.2b | -UK£142,584,065.00 | 22.4x | -51.7x | 6.3x |
Fri, 07 Oct 2022 | UK£7.4b | UK£1.2b | -UK£149,502,119.00 | 26.4x | -49.6x | 6.4x |
Sun, 04 Sep 2022 | UK£7.0b | UK£1.1b | -UK£146,610,750.00 | 34.3x | -48x | 6.3x |
Tue, 02 Aug 2022 | UK£7.3b | UK£1.1b | -UK£199,533,687.00 | 38.1x | -36.8x | 6.6x |
Thu, 30 Jun 2022 | UK£6.8b | UK£1.1b | -UK£167,521,479.00 | 35.3x | -40.6x | 6.1x |
Sat, 28 May 2022 | UK£7.2b | UK£1.1b | -UK£146,482,002.00 | 38.9x | -49.1x | 6.5x |
Mon, 25 Apr 2022 | UK£7.2b | UK£1.1b | -UK£91,620,330.00 | 37.9x | -78.9x | 6.6x |
Wed, 23 Mar 2022 | UK£7.4b | UK£1.1b | -UK£98,687,029.00 | 33x | -75.1x | 6.8x |
Fri, 18 Feb 2022 | UK£8.5b | UK£1.1b | -UK£119,732,737.00 | 35.3x | -70.7x | 7.8x |
Sun, 16 Jan 2022 | UK£9.7b | UK£1.1b | -UK£123,388,341.00 | 47.3x | -78.3x | 8.9x |
Tue, 14 Dec 2021 | UK£11.1b | UK£1.1b | -UK£121,180,343.00 | 54x | -91.8x | 10.2x |
Thu, 11 Nov 2021 | UK£11.9b | UK£1.1b | -UK£149,832,471.00 | 69.8x | -79.2x | 10.9x |
Sat, 09 Oct 2021 | UK£11.8b | UK£1.1b | -UK£148,479,118.00 | 68.8x | -79.5x | 10.7x |
Mon, 06 Sep 2021 | UK£12.9b | UK£1.1b | -UK£143,503,184.62 | 56.7x | -90x | 12.3x |
Wed, 04 Aug 2021 | UK£12.1b | UK£1.0b | -UK£172,541,949.91 | 29.6x | -70x | 11.8x |
Sat, 08 May 2021 | UK£11.5b | UK£1.0b | -UK£166,311,048.52 | 30.3x | -69.3x | 11.4x |
-65x
How does U.K. Biotech compare with similar industries?
GB Market | 0.65% | |
Healthcare | -1.46% | |
Biotech | -1.90% | |
Biotech | -1.90% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AREC Arecor Therapeutics | UK£1.48 | 11.3% +UK£4.6m | -43.3% | PS13.4x | |
4BB 4basebio | UK£9.75 | 3.2% +UK£3.8m | 43.4% | PS352.7x | |
FARN Faron Pharmaceuticals Oy | UK£1.40 | 3.7% +UK£3.4m | -55.6% | PE-3.6x | |
TRX Tissue Regenix Group | UK£0.69 | 2.9% +UK£1.3m | 13.2% | PS2.3x | |
PRTC PureTech Health | UK£1.97 | 0.2% +UK£1.1m | -3.2% | PS57.7x |